Baxter sees FY24 adjusted EPS $2.85-$2,95, consensus $2.93

Sees FY24 revenue up 2%, consensus $14.74B. The company said, “For full-year 2024: Baxter expects sales growth of approximately 2% on both a reported and constant currency basis. The company expects adjusted earnings, before special items, of $2.85 to $2.95 per diluted share.”